Cost-Effectiveness of Control-IQ+ Technology in Insulin-Treated Patients With Type 2 Diabetes in the United States.
Saved in:
| Title: | Cost-Effectiveness of Control-IQ+ Technology in Insulin-Treated Patients With Type 2 Diabetes in the United States. |
|---|---|
| Authors: | Al Rawashdh N; IQVIA, Real-World Evidence Solutions, Falls Church, Virginia, USA., Patel BV; Tandem Diabetes Care, San Diego, California, USA., Wang SM; Tandem Diabetes Care, San Diego, California, USA., Zur RM; IQVIA, Real-World Evidence Solutions, Falls Church, Virginia, USA., Anaya P; IQVIA, Real-World Evidence Solutions, Falls Church, Virginia, USA., Kahn EB; IQVIA, Real-World Evidence Solutions, Falls Church, Virginia, USA., Pinsker JE; Tandem Diabetes Care, San Diego, California, USA., Sasson-Katchalski R; Tandem Diabetes Care, San Diego, California, USA., Trahan AC; Tandem Diabetes Care, San Diego, California, USA., Messer LH; Tandem Diabetes Care, San Diego, California, USA., Assadi K; Tandem Diabetes Care, San Diego, California, USA., Kudva YC; Division of Endocrinology, Diabetes, Metabolism and Nutrition, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Beck RW; Jaeb Center for Health Research, Tampa, Florida, USA. |
| Source: | Diabetes, obesity & metabolism [Diabetes Obes Metab] 2026 Jul; Vol. 28 (7), pp. 6280-6290. Date of Electronic Publication: 2026 May 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42086278 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cost-Effectiveness of Control-IQ+ Technology in Insulin-Treated Patients With Type 2 Diabetes in the United States. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Al+Rawashdh+N%22">Al Rawashdh N</searchLink>; IQVIA, Real-World Evidence Solutions, Falls Church, Virginia, USA.<br /><searchLink fieldCode="AU" term="%22Patel+BV%22">Patel BV</searchLink>; Tandem Diabetes Care, San Diego, California, USA.<br /><searchLink fieldCode="AU" term="%22Wang+SM%22">Wang SM</searchLink>; Tandem Diabetes Care, San Diego, California, USA.<br /><searchLink fieldCode="AU" term="%22Zur+RM%22">Zur RM</searchLink>; IQVIA, Real-World Evidence Solutions, Falls Church, Virginia, USA.<br /><searchLink fieldCode="AU" term="%22Anaya+P%22">Anaya P</searchLink>; IQVIA, Real-World Evidence Solutions, Falls Church, Virginia, USA.<br /><searchLink fieldCode="AU" term="%22Kahn+EB%22">Kahn EB</searchLink>; IQVIA, Real-World Evidence Solutions, Falls Church, Virginia, USA.<br /><searchLink fieldCode="AU" term="%22Pinsker+JE%22">Pinsker JE</searchLink>; Tandem Diabetes Care, San Diego, California, USA.<br /><searchLink fieldCode="AU" term="%22Sasson-Katchalski+R%22">Sasson-Katchalski R</searchLink>; Tandem Diabetes Care, San Diego, California, USA.<br /><searchLink fieldCode="AU" term="%22Trahan+AC%22">Trahan AC</searchLink>; Tandem Diabetes Care, San Diego, California, USA.<br /><searchLink fieldCode="AU" term="%22Messer+LH%22">Messer LH</searchLink>; Tandem Diabetes Care, San Diego, California, USA.<br /><searchLink fieldCode="AU" term="%22Assadi+K%22">Assadi K</searchLink>; Tandem Diabetes Care, San Diego, California, USA.<br /><searchLink fieldCode="AU" term="%22Kudva+YC%22">Kudva YC</searchLink>; Division of Endocrinology, Diabetes, Metabolism and Nutrition, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Beck+RW%22">Beck RW</searchLink>; Jaeb Center for Health Research, Tampa, Florida, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100883645%22">Diabetes, obesity & metabolism</searchLink> [Diabetes Obes Metab] 2026 Jul; Vol. 28 (7), pp. 6280-6290. <i>Date of Electronic Publication: </i>2026 May 05. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100883645 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1463-1326 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214628902%22">14628902 </searchLink><i>NLM ISO Abbreviation: </i>Diabetes Obes Metab <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42086278 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/dom.70759 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 6280 Titles: – TitleFull: Cost-Effectiveness of Control-IQ+ Technology in Insulin-Treated Patients With Type 2 Diabetes in the United States. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Al Rawashdh N – PersonEntity: Name: NameFull: Patel BV – PersonEntity: Name: NameFull: Wang SM – PersonEntity: Name: NameFull: Zur RM – PersonEntity: Name: NameFull: Anaya P – PersonEntity: Name: NameFull: Kahn EB – PersonEntity: Name: NameFull: Pinsker JE – PersonEntity: Name: NameFull: Sasson-Katchalski R – PersonEntity: Name: NameFull: Trahan AC – PersonEntity: Name: NameFull: Messer LH – PersonEntity: Name: NameFull: Assadi K – PersonEntity: Name: NameFull: Kudva YC – PersonEntity: Name: NameFull: Beck RW IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2026 Jul Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1463-1326 Numbering: – Type: volume Value: 28 – Type: issue Value: 7 Titles: – TitleFull: Diabetes, obesity & metabolism Type: main |
| ResultId | 1 |